Biomedical conditions for MDD are used when trying to reduce self-blame by revealing the chemical imbalance in the brain, while external factors, environmental factors and societal influences all contribute to the biopsychosocial condition in which there is a decreased self-efficiency in handling depression, along with increased prognostic pessimism. The research supports that psychotherapy would be less effective than medication (Kemp,Lickel &Deacon, 2013). In reference to psychotherapy being less effective, another study concludes that using both biomedical conditions and treatment information appears to reduce stigmatization, which is important when handling those diagnosed with MDD (Lebowitz&Ahn,2012). Another study found that the biomedical condition led to a lower amount of personal and moral responsibility for depression and a worse prognosis. Therefore, psychosocial interventions are very ineffective (Deacon&Biard, 2009). Supporting the previous research, Kemp, Lickel, and Deacon revealed that chemical imbalance tests improved negative mood, and increased prognostic pessimism which supports that pharmacotherapy is much more effective than psychotherapy (2013). Both psychotherapy and pharmacotherapy have benefits, but studies conclude that pharmacotherapy and the biomedical condition have a higher success rate rather then psychotherapy and the biopsychosocial condition. The findings may suggest that using both pharmacotherapy and psychotherapy combined, may result in a higher success rate, rather than only using one type of therapy alone. With combined treatment, the results would be very successful because it reinforces and keeps close tabs on the Major Depressive Disorder Patient when seeing a therapist on a consistent
Biomedical conditions for MDD are used when trying to reduce self-blame by revealing the chemical imbalance in the brain, while external factors, environmental factors and societal influences all contribute to the biopsychosocial condition in which there is a decreased self-efficiency in handling depression, along with increased prognostic pessimism. The research supports that psychotherapy would be less effective than medication (Kemp,Lickel &Deacon, 2013). In reference to psychotherapy being less effective, another study concludes that using both biomedical conditions and treatment information appears to reduce stigmatization, which is important when handling those diagnosed with MDD (Lebowitz&Ahn,2012). Another study found that the biomedical condition led to a lower amount of personal and moral responsibility for depression and a worse prognosis. Therefore, psychosocial interventions are very ineffective (Deacon&Biard, 2009). Supporting the previous research, Kemp, Lickel, and Deacon revealed that chemical imbalance tests improved negative mood, and increased prognostic pessimism which supports that pharmacotherapy is much more effective than psychotherapy (2013). Both psychotherapy and pharmacotherapy have benefits, but studies conclude that pharmacotherapy and the biomedical condition have a higher success rate rather then psychotherapy and the biopsychosocial condition. The findings may suggest that using both pharmacotherapy and psychotherapy combined, may result in a higher success rate, rather than only using one type of therapy alone. With combined treatment, the results would be very successful because it reinforces and keeps close tabs on the Major Depressive Disorder Patient when seeing a therapist on a consistent